These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 20800373
1. Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer. Fenkell L, Assenholt M, Nielsen SK, Haie-Meder C, Pötter R, Lindegaard J, Tanderup K. Int J Radiat Oncol Biol Phys; 2011 Apr 01; 79(5):1572-9. PubMed ID: 20800373 [Abstract] [Full Text] [Related]
2. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. Georg P, Lang S, Dimopoulos JC, Dörr W, Sturdza AE, Berger D, Georg D, Kirisits C, Pötter R. Int J Radiat Oncol Biol Phys; 2011 Feb 01; 79(2):356-62. PubMed ID: 20385450 [Abstract] [Full Text] [Related]
3. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma. Clivio A, Kluge A, Cozzi L, Köhler C, Neumann O, Vanetti E, Wlodarczyk W, Marnitz S. Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):897-903. PubMed ID: 24119834 [Abstract] [Full Text] [Related]
4. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer. Yoshida K, Yamazaki H, Takenaka T, Kotsuma T, Yoshida M, Furuya S, Tanaka E, Uegaki T, Kuriyama K, Matsumoto H, Yamada S, Ban C. Int J Radiat Oncol Biol Phys; 2010 Jul 01; 77(3):765-72. PubMed ID: 19836165 [Abstract] [Full Text] [Related]
5. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. Georg P, Pötter R, Georg D, Lang S, Dimopoulos JC, Sturdza AE, Berger D, Kirisits C, Dörr W. Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):653-7. PubMed ID: 21345618 [Abstract] [Full Text] [Related]
6. [Locally advanced cervical cancer: Should intensity-modulated radiotherapy replace brachytherapy?]. Mazeron R, Gilmore J, Khodari W, Dumas I, Haie-Méder C. Cancer Radiother; 2011 Oct 01; 15(6-7):477-83. PubMed ID: 21880534 [Abstract] [Full Text] [Related]
7. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer. Nesseler JP, Charra-Brunaud C, Salleron J, Py JF, Huertas A, Meknaci E, Courrech F, Peiffert D, Renard-Oldrini S. Brachytherapy; 2017 Oct 01; 16(5):976-980. PubMed ID: 28694116 [Abstract] [Full Text] [Related]
8. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy: in regard to Georg et al. (Int J Radiat Oncol Biol Phys 2011;79:356-362). Shi M, Wei L. Int J Radiat Oncol Biol Phys; 2011 Sep 01; 81(1):315; author reply 315-6. PubMed ID: 21816293 [No Abstract] [Full Text] [Related]
9. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data. Yaparpalvi R, Mutyala S, Gorla GR, Butler J, Mah D, Garg MK, Kalnicki S. Brachytherapy; 2008 Sep 01; 7(4):336-42. PubMed ID: 18782683 [Abstract] [Full Text] [Related]
11. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer. Huang EY, Lin H, Hsu HC, Wang CJ, Chen HC, Sun LM, Hsiung CY. Gynecol Oncol; 2000 Dec 01; 79(3):406-10. PubMed ID: 11104610 [Abstract] [Full Text] [Related]
14. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, Weitmann H, Reinthaller A, Knocke TH, Wachter S, Kirisits C. Radiother Oncol; 2007 May 01; 83(2):148-55. PubMed ID: 17531904 [Abstract] [Full Text] [Related]
15. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer. Sun B, Yang D, Esthappan J, Garcia-Ramirez J, Price S, Mutic S, Schwarz JK, Grigsby PW, Tanderup K. Brachytherapy; 2015 May 01; 14(4):481-9. PubMed ID: 25958039 [Abstract] [Full Text] [Related]
16. Single versus customized treatment planning for image-guided high-dose-rate brachytherapy for cervical cancer: dosimetric comparison and predicting factor for organs at risk overdose with single plan approach. Chi A, Gao M, Sinacore J, Nguyen NP, Vali F, Albuquerque K. Int J Radiat Oncol Biol Phys; 2009 Sep 01; 75(1):309-14. PubMed ID: 19540070 [Abstract] [Full Text] [Related]
17. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer. Novetsky AP, Einstein MH, Goldberg GL, Hailpern SM, Landau E, Fields AL, Mutyala S, Kalnicki S, Garg M. Gynecol Oncol; 2007 Jun 01; 105(3):635-40. PubMed ID: 17331568 [Abstract] [Full Text] [Related]
18. Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer. Van de Kamer JB, De Leeuw AA, Moerland MA, Jürgenliemk-Schulz IM. Radiother Oncol; 2010 Feb 01; 94(2):248-53. PubMed ID: 20080309 [Abstract] [Full Text] [Related]
19. High-dose-rate interstitial brachytherapy for gynecologic malignancies. Beriwal S, Bhatnagar A, Heron DE, Selvaraj R, Mogus R, Kim H, Gerszten K, Kelley J, Edwards RP. Brachytherapy; 2006 Feb 01; 5(4):218-22. PubMed ID: 17118313 [Abstract] [Full Text] [Related]
20. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer. Nomden CN, de Leeuw AA, Moerland MA, Roesink JM, Tersteeg RJ, Jürgenliemk-Schulz IM. Int J Radiat Oncol Biol Phys; 2012 Mar 15; 82(4):1424-30. PubMed ID: 21669505 [Abstract] [Full Text] [Related] Page: [Next] [New Search]